Yolanda Prezado

Since February 2024, distinguished researcher Oportunius, CiMUS.  ERC consolidator grantee. Previously, senior group leader at Institut Curie (translational radiobiology), research director at CNRS and board-certified clinical medical physicist.  Since 2011, a permanent scientist at the CNRS. Leader of the "New Approaches in Radiotherapy" team  since 2013. Prize M and Mime Peyre of the French Academy of Science (2021) for her work in proton therapy.

She has a multidisciplinary profile (medical physics, radiobiology).

She has acted as the Chair of the scientific committee of the European Federation of Medical Physicist (integrating more than 8000 physicists in Europe), vice-chair of the international biophysics’ collaboration, chair of numerous working groups and committees. She is regularly invited to evaluation panels such as FWO or HCERES (French organism evaluating the activity of the labs)  and as member of the scientific committee of the main congresses in her domain. She is frequently requested as an evaluator in prestigious calls, such as ERC, H2020 and others.  She was chosen as the president of the 2024 European Congress of Medical Physics. 
She has directed 9 PhD theses and supervised the work of more than 10 postdocs. She has attracted more than 5 million Euros in the last 5 years. She has several collaborations with the main companies in the radiotherapy sector and several industrial grants. She has published more than 100 peer-reviewed papers, most of them as first or last author, and 12 invited review papers in prestigious journals of her domain. She is internationally recognized as a world leader in innovative radiotherapy techniques. She has participated in numerous conferences (> 100), many as an invited keynote and plenary speaker (>50).